Literature DB >> 19609390

High-performance liquid chromatographic method for determination of phenytoin in rabbits receiving sildenafil.

Alaa Khedr1, Mohamed Moustafa, Ashraf B Abdel-Naim, Abdulrahman Alahdal, Hisham Mosli.   

Abstract

A validated high-performance liquid chromatographic (HPLC) method for determination of phenytoin (PHN), para-hydroxy metabolite of phenytoin (POH) and sildenafil (SIL) in rabbit plasma is described. The method is based on extraction on Sep-Pak C18 solid support using ethyl acetate and ether as eluents and monitoring at 220 nm. The extracted samples were analyzed by HPLC using Agilent Zorbax Extended C(18) column (150 mm x 4.6 mm internal diameter) and isocratic elution with a mobile phase consist of 29% acetonitrile and 71% sodium acetate solution (0.02 M, pH 4.6). The method was fully validated for linearity and range, selectivity, precision, stability, recovery, and robustness. The linearity of the method was in the range of 0.15 to 39 microg /ml for PHN and 0.15 to 33 microg/ml for both POH and SIL. Limits of detection (LOD) of PHN, POH, and SIL were 0.15 +/- 0.01, 0.15 +/- 0.01, and 0.15 +/- 0.01 microg/ml, respectively. The % recovery of PHN, POH, and SIL from rabbit plasma were, 101.88 +/- 0.12, 99.16 +/- 0.25, and 99.49 +/- 0.33, respectively. The method was applied on plasma collected from rabbits at different time intervals after receiving 30 mg/kg PHN-Na with (and without) 8 mg/kg SIL citrate.

Entities:  

Keywords:  chromatography; phenytoin; rabbit plasma; sildenafil

Year:  2008        PMID: 19609390      PMCID: PMC2701166          DOI: 10.4137/aci.s658

Source DB:  PubMed          Journal:  Anal Chem Insights        ISSN: 1177-3901


  19 in total

1.  Determination of phenytoin in plasma by molecularly imprinted solid-phase extraction.

Authors:  A Bereczki; A Tolokán; G Horvaia; V Horváth; F Lanza; A J Hall; B Sellergren
Journal:  J Chromatogr A       Date:  2001-09-28       Impact factor: 4.759

2.  Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction.

Authors:  T A C Vermeij; P M Edelbroek
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-06-30       Impact factor: 3.205

3.  Certain 5-phenyl-5-(substituted phenyl)-hydantoins.

Authors:  J W MELTON; H R HENZE
Journal:  J Am Chem Soc       Date:  1947-08       Impact factor: 15.419

Review 4.  Pharmacologic treatment strategies for sexual dysfunction in patients with epilepsy and depression.

Authors:  Glen L Stimmel; Mary A Gutierrez
Journal:  CNS Spectr       Date:  2006-08       Impact factor: 3.790

5.  Simultaneous determination of phenytoin, carbamazepine, and 10,11-carbamazepine epoxide in human plasma by high-performance liquid chromatography with ultraviolet detection.

Authors:  M M Bhatti; G D Hanson; L Schultz
Journal:  J Pharm Biomed Anal       Date:  1998-03       Impact factor: 3.935

6.  Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, phenobarbital, and primidone in human plasma by SPME-GC-TSD.

Authors:  M E C Queiroz; S M Silva; D Carvalho; F M Lanças
Journal:  J Chromatogr Sci       Date:  2002-04       Impact factor: 1.618

7.  Simultaneous determination of sildenafil and N-desmethyl sildenafil in human plasma by high-performance liquid chromatography method using electrochemical detection with application to a pharmacokinetic study.

Authors:  M Al-Ghazawi; M Tutunji; S Aburuz
Journal:  J Pharm Biomed Anal       Date:  2006-08-22       Impact factor: 3.935

8.  Quantification of phenytoin and its metabolites in equine plasma and urine using high-performance liquid chromatography.

Authors:  F Guan; C E Uboh; L R Soma; E K Birks; D Teleis; J A Rudy; A O Watson; D S Tsang
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-09-15

Review 9.  Epilepsy and erectile dysfunction: a review.

Authors:  M Smaldone; T Sukkarieh; A Reda; A Khan
Journal:  Seizure       Date:  2004-10       Impact factor: 3.184

10.  Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.

Authors:  M Claesen; M A Moustafa; J Adline; D Vandervorst; J H Poupaert
Journal:  Drug Metab Dispos       Date:  1982 Nov-Dec       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.